Beta-alanine potentiation of [3H]flunitrazepam binding to rat spinal cord homogenates

Neurosci Lett. 1990 Apr 6;111(3):241-5. doi: 10.1016/0304-3940(90)90268-e.

Abstract

The effect of beta-alanine, gamma-aminobutyric acid (GABA), and other functionally related amino acids on [3H]flunitrazepam binding to rat spinal cord homogenates was studied. beta-Alanine potentiated [3H]flunitrazepam binding by 40% and GABA by 88%. Taurine increased the binding by 19%. Hypotaurine produced an 11% increase. No significant effect was seen in glycine, alanine, serine, valine or the dipeptide carnosine. The beta-alanine increase in [3H]flunitrazepam binding was completely inhibited by 10 microM strychnine, whereas the GABA increase required 0.1 mM strychnine to be fully suppressed. Results suggest that beta-alanine specifically potentiates binding of [3H]flunitrazepam in rat spinal cord homogenates.

MeSH terms

  • Alanine / pharmacology*
  • Amino Acids / pharmacology
  • Animals
  • Drug Synergism
  • Flunitrazepam / metabolism*
  • Kinetics
  • Radioligand Assay
  • Rats
  • Rats, Inbred Strains
  • Spinal Cord / drug effects*
  • Strychnine / antagonists & inhibitors
  • Tritium
  • beta-Alanine / pharmacology*
  • gamma-Aminobutyric Acid / pharmacology

Substances

  • Amino Acids
  • Tritium
  • beta-Alanine
  • gamma-Aminobutyric Acid
  • Flunitrazepam
  • Strychnine
  • Alanine